LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | OSI-027 | 3.33 | uM | LJP6 | 72 | hr | 765 | 1165 | 3101 | 0.3756 | 0.2314 |
Hs 578T | OSI-027 | 10 | uM | LJP6 | 72 | hr | 765 | 882 | 3101 | 0.2847 | 0.0730 |
Hs 578T | WYE-125132 | 0.12 | uM | LJP6 | 72 | hr | 765 | 997 | 3101 | 0.3216 | 0.1400 |
Hs 578T | WYE-125132 | 0.37 | uM | LJP6 | 72 | hr | 765 | 923 | 3101 | 0.2976 | 0.0973 |
Hs 578T | AT-7519 | 0.04 | uM | LJP6 | 72 | hr | 765 | 2849 | 3101 | 0.9193 | 0.9179 |
Hs 578T | AZD7762 | 0.37 | uM | LJP6 | 72 | hr | 765 | 565 | 3101 | 0.1824 | -0.1395 |
Hs 578T | JW-7-24-1 | 1.11 | uM | LJP6 | 72 | hr | 765 | 1915 | 3101 | 0.6176 | 0.5753 |
Hs 578T | KIN001-043 | 0.12 | uM | LJP6 | 72 | hr | 765 | 3135 | 3101 | 1.0111 | 1.0110 |
Hs 578T | AT-7519 | 0.12 | uM | LJP6 | 72 | hr | 765 | 2279 | 3101 | 0.7348 | 0.7168 |
Hs 578T | AT-7519 | 0.37 | uM | LJP6 | 72 | hr | 765 | 531 | 3101 | 0.1712 | -0.1659 |
Hs 578T | AT-7519 | 3.33 | uM | LJP6 | 72 | hr | 765 | 300 | 3101 | 0.0968 | -0.3718 |
Hs 578T | AT-7519 | 10 | uM | LJP6 | 72 | hr | 765 | 266 | 3101 | 0.0862 | -0.4158 |
Hs 578T | AZD7762 | 1.11 | uM | LJP6 | 72 | hr | 765 | 497 | 3101 | 0.1604 | -0.1920 |
Hs 578T | AZD7762 | 3.33 | uM | LJP6 | 72 | hr | 765 | 466 | 3101 | 0.1504 | -0.2176 |
Hs 578T | AZD8055 | 0.04 | uM | LJP6 | 72 | hr | 765 | 1121 | 3101 | 0.3617 | 0.2086 |
Hs 578T | AZD8055 | 0.12 | uM | LJP6 | 72 | hr | 765 | 1030 | 3101 | 0.3322 | 0.1585 |
Hs 578T | AZD8055 | 3.33 | uM | LJP6 | 72 | hr | 765 | 829 | 3101 | 0.2677 | 0.0406 |
Hs 578T | AZD8055 | 10 | uM | LJP6 | 72 | hr | 765 | 510 | 3101 | 0.1650 | -0.1859 |
Hs 578T | Sorafenib | 0.12 | uM | LJP6 | 72 | hr | 765 | 3587 | 3101 | 1.1563 | 1.1491 |
Hs 578T | Sorafenib | 0.37 | uM | LJP6 | 72 | hr | 765 | 3768 | 3101 | 1.2151 | 1.2026 |
Hs 578T | GW843682X | 0.04 | uM | LJP6 | 72 | hr | 765 | 3096 | 3101 | 0.9983 | 0.9982 |
Hs 578T | Palbociclib | 3.33 | uM | LJP6 | 72 | hr | 765 | 1511 | 3101 | 0.4875 | 0.4010 |
Hs 578T | PF562271 | 0.04 | uM | LJP6 | 72 | hr | 765 | 2769 | 3101 | 0.8928 | 0.8908 |
Hs 578T | Afatinib | 3.33 | uM | LJP6 | 72 | hr | 765 | 2529 | 3101 | 0.8157 | 0.8080 |
Hs 578T | Afatinib | 1.11 | uM | LJP6 | 72 | hr | 765 | 2709 | 3101 | 0.8734 | 0.8702 |